respiratory
Lung cancer

Biomarker blood test may detect earlier stage disease in lung cancer screening

The addition of a biomarker blood test in a lung cancer screening program can increase the detection of early stage disease and may offer a more targeted approach, a UK study has shown. An autoantibody blood test followed by imaging detected more stage I/II lung cancers in a high risk screening cohort and could potentially ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic